News Gilead Sciences, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 10:11:10 2024-04-26 am EDT			5-day change	1st Jan Change
65.14 ^USD	-0.21%		-2.67%	-19.79%

04:08pm	Morgan Stanley Adjusts Price Target on Gilead Sciences to $78 From $80	MT
03:26pm	Gilead Sciences Receives FDA Approval for Updated Label of Biktarvy	MT

Morgan Stanley Adjusts Price Target on Gilead Sciences to $78 From $80	10:08am	MT
Gilead Sciences Receives FDA Approval for Updated Label of Biktarvy	09:26am	MT
Well, it isn't as bad as feared...	09:16am
FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV	08:02am	BU
News Highlights : Top Company News of the Day - Friday at 1 AM ET	01:15am	DJ
News Highlights : Top Company News of the Day - Thursday at 11 PM ET	11:15pm	DJ
News Highlights : Top Company News of the Day - Thursday at 9 PM ET	09:15pm	DJ
News Highlights : Top Company News of the Day - Thursday at 5 PM ET	Apr. 25	DJ
News Highlights : Top Company News of the Day - Thursday at 7 PM ET	Apr. 25	DJ
Gilead Sciences Q1 Tops Estimates, Updates Outlook	Apr. 25	MT
Gilead Sciences Posts Higher 1Q Sales, Swings to Loss on Charges	Apr. 25	DJ
Transcript : Gilead Sciences, Inc., Q1 2024 Earnings Call, Apr 25, 2024	Apr. 25
(GILD) GILEAD SCIENCES Forecasts Fiscal Year 2024 EPS Range $3.45 - $3.85	Apr. 25	MT
Earnings Flash (GILD) GILEAD SCIENCES Reports Q1 Revenue $6.69B, vs. Street Est of $6.348B	Apr. 25	MT
Gilead: Q1 Earnings Snapshot	Apr. 25	AQ
Gilead Sciences Announces First Quarter 2024 Financial Results	Apr. 25	BU
Gilead Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Gilead posts quarterly loss, revenue rises 5%	Apr. 25	RE
Gilead Sciences, Inc. Revises Earnings Guidance for the Full Year 2024	Apr. 25	CI
Gilead Sciences, Inc. Declares a Dividend for the Second Quarter of 2024, Payable on June 27, 2024	Apr. 25	CI

No results for this search